Literature DB >> 29269356

Sensory neuronopathy associated with cholangiocarcinoma diagnosed 6 years after symptom onset.

Alexander M Rossor1, Julian Blake2, Theodora Pissanou3, Mary M Reilly1.   

Abstract

A pure sensory neuronopathy (also referred to as a sensory ganglionopathy) is one of a handful of classical neurological paraneoplastic syndromes. Current guidelines recommend that in cases of sensory neuronopathy, a search for an underlying malignancy be pursued for up to 4 years. We report the case of a 52-year-old woman with a sensory neuronopathy who was eventually diagnosed with a cholangiocarcinoma 6 years after the onset of her disease. A CT fluorodeoxyglucose positron emission tomography (FDG-PET) scan performed 18 and 24 months after disease onset failed to identify an underlying neoplasm. Immunomodulatory treatment with corticosteroids, intravenous immunoglobulins and plasma exchange were ineffective. Investigations for Sjogren's disease were negative. A third FDG-PET performed 6 years after symptom onset identified a cholangiocarcinoma, which was confirmed histologically following open resection. Since the tumour was removed, our patient's condition has not progressed, but there has been no improvement and she remains severely disabled. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  hepatic cancer; neuromuscular disease; peripheral nerve disease

Mesh:

Substances:

Year:  2017        PMID: 29269356      PMCID: PMC5743886          DOI: 10.1136/bcr-2016-217844

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Paraneoplastic syndromes in cancer: Case 3. Parathyroid hormone-related hypercalcemia in cholangiocarcinoma.

Authors:  Yun Yen; Peiguo G Chu; Wei Feng
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

Review 2.  The dorsal root ganglion under attack: the acquired sensory ganglionopathies.

Authors:  Sarah I Sheikh; Anthony A Amato
Journal:  Pract Neurol       Date:  2010-12

3.  Asymmetric sensory ganglionopathy: a case series.

Authors:  Celedonio Marquez-Infante; Sinéad M Murphy; Liberty Mathew; Ali Alsanousi; Michael P Lunn; Sebastian Brandner; Tarek A Yousry; Julian Blake; Mary M Reilly
Journal:  Muscle Nerve       Date:  2013-06-06       Impact factor: 3.217

4.  Alopecia: a common paraneoplastic manifestation of cholangiocarcinoma in humans and animals.

Authors:  Efstathios Antoniou; Panorea Paraskeva; Anastasios Smyrnis; Kostas Konstantopoulos
Journal:  BMJ Case Rep       Date:  2012-06-15

5.  Necrolytic migratory erythema with cholangiocarcinoma: Pseudoglucagonoma syndrome.

Authors:  Koji Chiyomaru; Toshihiro Takai; Akiko Ohashi; Chikako Nishigori
Journal:  Eur J Dermatol       Date:  2010-02-05       Impact factor: 3.328

6.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.